1-nitrohydroxyphenyl-n-benzoylalanine has been researched along with Lung Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Baños, N; Cebrián, A; Cedeño, M; Corral, JM; Dómine, M; Galeano, C; García-Foncillas, J; Mahillo-Fernández, I; Puerto-Nevado, LD; Río-Vilariño, A | 1 |
Li, LJ; Xuan, JZ; Zheng, HN | 1 |
2 other study(ies) available for 1-nitrohydroxyphenyl-n-benzoylalanine and Lung Neoplasms
Article | Year |
---|---|
Galectin-1, a novel promising target for outcome prediction and treatment in SCLC.
Topics: Benzamides; Galectin 1; Humans; Lung Neoplasms; Small Cell Lung Carcinoma | 2022 |
Correlation of
Topics: Adenocarcinoma of Lung; Biomarkers; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden; Tumor Microenvironment | 2023 |